Despite substantial agreement with points made by Andrew C. Leon, PhD, in his article, I am not in complete agreement in a few areas. The definition of noninferiority proposed by Leon allows drugs somewhat less effective than placebo to be characterized as noninferior to placebo, and 2 active drugs may each be simultaneously noninferior to the other. Moreover, including a placebo arm in comparing 2 active drugs is of no use in deciding whether the study is well designed or not, since a significant difference between one of the active arms and the placebo may be due to chance or to a bias in the design. An alternative view of the situation is presented. © Copyright 2011 Physicians Postgraduate Press, Inc.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Kraemer, H. C. (2011). Another point of view: Superiority, noninferiority,and the role of active comparators. Journal of Clinical Psychiatry. Physicians Postgraduate Press Inc. https://doi.org/10.4088/JCP.10com06607whi